A new insight into the role of CART peptide in serotonergic function and anxiety

Abstract Cocaine and amphetamine-regulated transcript (CART) peptide has been established as a contributor to anxiogenic behavior. Genetic mutations in the CART gene are associated with anxiety and depression, and increased CART expression has been reported in suicide victims. Extensive research has focused on the role of CART peptide in mesolimbic neurocircuitry, but its involvement in the dorsal raphe nucleus (DRN) and serotonin (5HT) system remains unexplored. Here we demonstrate that CART processes are proximal to 5HT DRN neurons and that microinjection of CART (55-102) peptide into the DRN has an anxiogenic effect in mice. Furthermore, central CART administration reduced cfos activation in 5HT neurons of the ventral DRN, which is a putative reward/anti-stress circuit. The inhibitory effect of CART on 5HT DRN neuronal function and local 5HT release is further demonstrated with in vivo fiber photometry coupled with calcium and 5HT biosensors and by mass spectrometry. Moreover, using Cre-dependent retrograde tracing, we observed DRN-projecting CART neurons in the Edinger Westphal nucleus (EW), nucleus accumbens (NAc), and various hypothalamic nuclei including the ventromedial hypothalamus (VMH). Interestingly, based on ex vivo electrophysiological recordings, acute stress increased excitability in DRN-projecting CART neurons located in the EW, but not in the VMH or NAc. This suggests that the stress may promote anxiety-like behavior by activating the EW CART →5HT DRN circuit that ultimately inhibits 5HT transmission. In sum, understanding the intricate dynamics of the CARTergic and 5HTergic systems proves crucial in addressing 5HT-related dysfunctions, providing invaluable insights into both health and disease.